← back to search

Dominik J. Schaer

University of Zurich · CH
Area of research
Cell Biology · Molecular Biology
Research interest
Research interests include Hemoglobin structure and function, Heme Oxygenase-1 and Carbon Monoxide, Hemoglobinopathies and Related Disorders, and Neonatal Health and Biochemistry.
h-index
49
citations
8,326
works
176
NIH funding
primary concept
Medicine
email

Recent publications

Haptoglobin and Hemopexin Redirect Heme-Driven Oxidative Stress and Neurotoxicity in Organotypic Brain Slices.
2026cited by 0position: contributordoi
An ontogeny-cytokine code determines macrophage response polarity and tumor outcomes.
2026cited by 0position: contributordoi
Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal)
2026cited by 0position: contributordoi
Sickle cell disease-associated pulmonary hypertension: an integrated framework linking pathologies, mechanisms, and clinical phenotypes
eBioMedicine 2026cited by 0position: contributordoi
Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in Sheep.
2025cited by 7position: contributordoi
Patterns of hemolysis, erythropoiesis, and iron distribution define unique disease trajectories in three mouse models of genetic anemia.
2025cited by 1position: contributordoi
Stress-NRF2 response axis polarizes tumor macrophages and undermines immunotherapy.
2025cited by 1position: contributordoi
A CSF-cytokine code predicts macrophage response polarity and tumor outcomes
2025cited by 0position: contributordoi
A stress-NRF2 response axis polarises tumor macrophages and undermines immunotherapy
2025cited by 0position: contributordoi
Navigating Hemolysis and the Renal Implications of Hemoglobin Toxicity in Cardiac Surgery.
2024cited by 8position: contributordoi
C1-inhibitor to prevent intracerebral hemorrhage-related secondary brain injury.
2024cited by 1position: contributordoi
Effect of a nurse-led integrated care intervention on quality of life and rehospitalisation in patients with severe exacerbation of COPD-a pilot study.
2024cited by 1position: contributordoi
Haptoglobin Treatment for Aneurysmal Subarachnoid Hemorrhage: Review and Expert Consensus on Clinical Translation.
2023cited by 27position: contributordoi
Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance.
2023cited by 26position: contributordoi
Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity.
2023cited by 13position: contributordoi
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region.
2023cited by 11position: contributordoi
VEXAS Syndrome With Tracheal Involvement but Absence of Vasculitis in FDG PET/CT.
2023cited by 6position: contributordoi
Clinical potential of automated convolutional neural network-based hematoma volumetry after aneurysmal subarachnoid hemorrhage.
2023cited by 5position: contributordoi
Blood oxygenation-level dependent cerebrovascular reactivity imaging as strategy to monitor CSF-hemoglobin toxicity.
2023cited by 5position: contributordoi
Targeting Metabolic Vulnerabilities to Overcome Prostate Cancer Resistance: Dual Therapy with Apalutamide and Complex I Inhibition.
2023cited by 3position: contributordoi
Association between iron deficiency and hospitalization rate in community-dwelling older adults: A 3-year prospective observational study of DO-HEALTH.
2023cited by 2position: contributordoi
Haptoglobin attenuates cerebrospinal fluid hemoglobin-induced neurological deterioration in sheep
2023cited by 0position: contributordoi
Haptoglobin attenuates cerebrospinal fluid hemoglobin-induced neurological deterioration in sheep
2023cited by 0position: contributordoi
Transcriptomic gene profiles in an <i>ex vivo</i> model of erythropoiesis to unravel molecular pathomechanisms of Sickle Cell Disease
2023cited by 0position: contributordoi
Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics.
2022cited by 100position: contributordoi
Erythrophagocytes in hemolytic anemia, wound healing, and cancer.
2022cited by 31position: contributordoi
Heme-stress activated NRF2 skews fate trajectories of bone marrow cells from dendritic cells towards red pulp-like macrophages in hemolytic anemia.
2022cited by 30position: contributordoi
The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.
2022cited by 24position: contributordoi
Iron deficiency and biomarkers of inflammation: a 3-year prospective analysis of the DO-HEALTH trial.
2022cited by 22position: contributordoi
Spatial transcriptome analysis defines heme as a hemopexin-targetable inflammatoxin in the brain.
2022cited by 22position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 27 papers (2020–2026)Raphael M. Buzzi · University of Zurich13 papers (2021–2026) · 9 papers (2020–2026)Michael Hugelshofer · University of Zurich9 papers (2019–2025)Kevin Akeret · The University of Melbourne8 papers (2019–2025)Onur Boyman · Icahn School of Medicine at Mount Sinai7 papers (2020–2023)Bart R. Thomson · Antoni van Leeuwenhoek Nederlands Kanker Instituut6 papers (2021–2025)Ulrike Held · Technical University of Munich6 papers (2020–2025)Henning Richter · University of Zurich6 papers (2019–2025)Luca Regli · University of Turin5 papers (2019–2022)Heike A. Bischoff-Ferrari · BioBank Japan4 papers (2022–2023)Rok Humar · University Hospital Zurich4 papers (2021–2023)Bernd Bodenmiller · Life Science Zurich4 papers (2020–2021)Jakob Nilsson · Lindenhofspital3 papers (2020–2020)Yves Zurbuchen · University Hospital of Zurich3 papers (2020–2020)Frauke Seehusen · University of Veterinary Medicine3 papers (2023–2025)Carlo Cervia · University of Zurich3 papers (2020–2020)Alain Rudiger · Spital Limmattal3 papers (2020–2020)Adriano Aguzzi · Amyloidosis Foundation3 papers (2020–2021)Katrin Beckmann · Albert- Heim- Stiftung3 papers (2023–2025)